Chugai und Debiopharm Group™ geben exklusiven Lizenzvertrag für Krebsmedikament FF284 (Debio 1347) bekannt
This document is hosted externally.
Unless the owner has removed it from the web, you can access the full document via its original URL:
https://www.debiopharm.com/wp-content/uploads/2018/08/PR-Debiopharm-Chugai-8012013-DE.pdfUnless the owner has removed it from the web, you can access the full document via its original URL:
See similar contracts (1)
Alternatively, you can try searching for similar contracts: